Hyoscine medicine
Reading File
Finding Sources
Searching PubMed
hyoscine scopolamine clinical uses
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Here is a comprehensive overview of hyoscine (scopolamine) based on authoritative pharmacology textbooks:
Hyoscine (Scopolamine)
What It Is
Hyoscine is a naturally occurring belladonna alkaloid derived from plants such as Hyoscyamus niger (henbane) and Datura species. It is a competitive antagonist at muscarinic acetylcholine receptors (M1-M5), producing widespread anticholinergic effects throughout the body. It comes in two main salt forms with importantly different properties:
| Form | Trade Name | CNS Penetration | Main Use |
|---|---|---|---|
| Hyoscine hydrobromide (scopolamine) | Scopoderm (patch) | Yes - lipophilic, crosses BBB | Motion sickness, premedication, secretion control |
| Hyoscine butylbromide | Buscopan | No - quaternary ammonium, does NOT cross BBB | GI antispasmodic |
Mechanism of Action
Hyoscine blocks muscarinic (cholinergic) receptors, producing:
- Reduced smooth muscle tone and spasm (GI, urinary tract, bronchi)
- Reduced glandular secretions (salivary, bronchial, gastric)
- Mydriasis and cycloplegia (pupil dilation, loss of lens accommodation)
- Tachycardia (block of vagal slowing)
- CNS effects (sedation, amnesia, anti-motion sickness) - only hyoscine hydrobromide
Clinical Uses
1. Motion Sickness (Hydrobromide)
Hyoscine (scopolamine) is considered one of the best agents for motion sickness prevention. It acts on the vestibular system and vomiting center in the brainstem. Its oral/parenteral form has a very high rate of anticholinergic side effects, so the transdermal patch (1.5 mg every 3 days) is strongly preferred for tolerability. - Katzung's Basic and Clinical Pharmacology, 16th Ed.
The transdermal patch (Scopoderm) is also useful when the oral route is unavailable for managing retained respiratory secretions, for example in palliative/end-of-life care. - Scott-Brown's Otorhinolaryngology, Vol. 1
2. Postoperative Nausea and Vomiting (PONV)
Used as a prophylactic antiemetic in the perioperative setting. As a premedication (combined with papaveretum in some regimens), it reduces secretions and provides sedation/amnesia. - Pye's Surgical Handicraft, 22nd Ed.
3. Antispasmodic - GI (Butylbromide / Buscopan)
Hyoscine butylbromide exerts a topical spasmolytic action on GI smooth muscle. It does not cross the blood-brain barrier, so central side effects (confusion, sedation, hallucinations) are rare. Used for irritable bowel syndrome, renal/biliary colic. - Maudsley Prescribing Guidelines, 15th Ed.
4. Control of Secretions / Drooling
- In palliative care, hyoscine hydrobromide is one of three key antisecretory drugs (alongside glycopyrronium and hyoscine butylbromide) used to manage death rattle (retained respiratory secretions in dying patients). Glycopyrronium may be preferred because it avoids CNS agitation. - Scott-Brown's Otorhinolaryngology
- In children with neurological conditions causing drooling, transdermal hyoscine hydrobromide patches are the first-line treatment used by most UK paediatricians. They are effective and waterproof, changed every 3 days. However, they carry up to a 71% incidence of side effects in some series. - Scott-Brown's Vol. 2
- For clozapine-induced hypersalivation in psychiatry, hyoscine hydrobromide is one option, though glycopyrrolate may be preferred. - Maudsley Prescribing Guidelines
Adverse Effects
| System | Effects |
|---|---|
| CNS | Sedation, amnesia, confusion, hallucinations (especially in elderly) |
| Eye | Dry eyes, dilated pupils (photophobia), blurred vision |
| GI | Dry mouth, constipation |
| Urinary | Urinary retention |
| Skin | Reactions to transdermal patch adhesive (common) |
| Cardiovascular | Tachycardia |
Cognitive impairment is a particularly significant concern. Hyoscine hydrobromide is so reliably memory-impairing that it is used experimentally to produce a dementia model (the scopolamine challenge test). Elderly patients and those with Alzheimer's disease are especially vulnerable at low doses. - Maudsley Prescribing Guidelines, 15th Ed.
Contraindications / Special Precautions
- Avoid in dementia / Alzheimer's disease - worsens cognition significantly
- Avoid in the elderly generally (higher sensitivity to anticholinergic effects)
- Glaucoma (angle-closure) - mydriasis raises intraocular pressure
- Urinary outflow obstruction (risk of acute retention)
- Myasthenia gravis
Formulations & Doses
| Form | Dose | Route |
|---|---|---|
| Transdermal patch (hydrobromide) | 1.5 mg every 3 days | Skin (post-auricular area preferred) |
| Injection (hydrobromide) | 0.2-0.4 mg | IM / IV / SC |
| Oral (hydrobromide) | Variable | Oral (less effective than patch) |
| Tablet/injection (butylbromide - Buscopan) | 10-20 mg | Oral / IV for spasm |
Poisoning / Toxicology
In overdose (or from plant ingestion - henbane, datura), hyoscine causes the classic anticholinergic toxidrome: hot, dry flushed skin, tachycardia, urinary retention, dilated pupils, agitation, delirium, and seizures. It is detectable on toxicological analysis of blood and tissue specimens. - Parikh's Medical Jurisprudence & Toxicology
Summary: Hyoscine is a versatile anticholinergic with two distinct clinical personalities - the hydrobromide (lipophilic, CNS-active) for motion sickness, premedication, and secretion control; and the butylbromide (peripheral-only) for GI spasm. Its main limitation is a broad adverse effect profile, particularly CNS effects in the elderly and vulnerable populations.
This is a shared conversation. Sign in to Orris to start your own chat.